Zyga EVoluSIon Study Enrolls 100th Patient

Zyga Technology enrolled the 100th patient in EVoluSIon (EVSI), a prospective, 40-site, 250-patient trial investigating long-term fusion and pain reduction in patients undergoing SImmetry® Sacroiliac Joint Fusion. Enrollment had commenced just over one year ago.

At 24 months post-op, 94% of SImmetry patients had evidence of bridging bone...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us